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Objective: To investigate the effects of co-transfection of miR-520c-3p and miR-132 on
proliferation and apoptosis of hepatocellular carcinoma Huh7.
Methods: Hepatocellular carcinoma Huh7 was cultured in vitro and lipidosome was
used to transfect miR-520c-3p and miR-132, respectively or together. The effects of
transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of Huh7 were
detected by CCK8 and Annexin V staining and ﬂow cytometry, and the expression level
of the targeted gene of over-expressed miR-520c-3p and miR-132 was determined by
Western blot and realtime PCR.
Results: Compared with the control group, the proliferation ability of Huh7 of the single
transfected and co-transfected miR-520c-3p and miR-132 decreased signiﬁcantly, and the
apoptosis ratio increased distinctly (P < 0.05). Besides, the effect of the co-transfection
group was better than that of the single transfection group. The protein levels of GPC3
(Glypican-3) and YAP (Yes-associated protein), the target genes transfected only by miR-
520c-3p and miR-132, respectively, reduced obviously (P < 0.05), which was similar
with the co-infected cells, but cells transfected by miR-132 only showed a decrease of
YAP.
Conclusions: The co-transfection of miR-520c-3p and miR-132 can target-regulate the
expression of GPC3 and YAP, enhance the exhibition effect on proliferation of hepa-
tocellular carcinoma Huh7 and induce cell apoptosis synergistically.1. Introduction
Liver cancer is a common malignancy worldwide with high
morbidity and mortality rates which brings heavy burdens to
societies and families. In our country, there is a severe trend ofcarcinogenic risks such as hepatitis B infection. Its morbidity
rate reaches about 5–10 times as much as that in developed
countries. The death toll from liver cancer accounts for about
50% of the total [1,2]. Traditional surgery, chemotherapy and
radiotherapy do not work ideally. A large amount of
researches have proved that many microRNA are closely
related to the growth, metastasis and microenvironment of
tumors [3–5]. Therefore, microRNA has been the effective
target tool for inhibiting the growth and metastasis of tumors.
There are researches demonstrating that miR-520c-3p and
miR-132 express abnormally in hepatocellular carcinoma and
are related to the proliferation, apoptosis and metastasis of he-
patocellular carcinoma [6,7]. This study aimed to investigate the
correlation of miR-520c-3p and miR-132 in the proliferation andle under the CC BY-NC-ND license (http://
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transfect hepatocellular carcinoma Huh7 and explore its mode
of action.
2. Materials and methods
2.1. Materials
Human hepatocellular carcinoma cell line Huh7 used in this
study was provided by Shanghai Cell Bank of Chinese Academy
of Sciences; fetal bovine serum, antibiotics, trypsin, DMEM
medium and Opti-MEM were all purchased from Gibco-BRL
and transfection reagent Lipofectamine™ 2000, Trizol reagent
and Annexin V-FITC apoptosis detection kits were bought from
Invitrogen; the primer was designed and compounded by San-
gon Biotech; reverse transcription kits and ﬂuorescence quanti-
tation kits were from Takara; miR-520c-3p, miR-132 mimics
and mimics negative controls were all bought from Ribobio
(Guangzhou, China); rabbit-anti-human GPC3, YAP, GAPDH
primary antibody and HRP secondary antibody were from




A DMEM medium containing 10% fetal bovine serum was
prepared. The frozen Huh7 cells were taken out from the liquid
nitrogen tank and thawn repeatedly and rapidly in a water bath at
37 C. Then, 10 mL preheated complete culture medium
absorbed from the super clean bench was taken to a centrifuge
tube, washed to remove DMSO of the cell suspension and
centrifuged at 1000 r/min for 5 min. After that, the supernatant
was discarded. Moderate culture solution was added to re-
suspend cells and then it was moved to the culture ﬂask and
cultured conventionally at 37 C in 5% CO2 incubator. The
solution was changed on the next morning. When Huh-7 grew
and fused to a single layer, it was washed by PBS to have
digestive transfer culture by 0.25% trypsin.
2.2.2. MiR transfection
miR-520c-3p, miR-132 mimics and mimics negative control
freeze-dried powder was made into 20 mM stock solution by
RNase-free H2O and stored respectively to avoid repetitive
freeze-thawing. The day before transfection, Huh-7 cells were
incubated to 24-well plate or 96-well plate holes containing
complete medium and transfected when the cell concentration
reached 70% with the mimic concentration of 100 nM and three
complex holes. A total of 50 mL Opti-MEM was applied to
dilute miR and Lipofectamine™ 2000 blowing and absorbing
slightly for 3–5 times till it was mixed evenly. The transfection
reagent and miR diluent were mixed, also blew and absorbed
slightly for 3–5 times till it was mixed evenly, and placed still at
room temperature for 5 min. Then, the mixed solution was added
into the primary culture medium. The transfection rate was
detected after 24 h and the cell biological characteristics were
tested after 48 h.2.2.3. Detection of CCK8 cell viability
A total of 10 mL CCK8 solution was added into every well on
the 96-well plate after transfecting for 48 h with the greatest extentto avoid bringing air bubbles. The culture plate was incubated in an
incubator for 2 h. A microplate reader was employed to determine
the absorbance at 450 nm. Cell viability (%) = [A (mimic) − A
(blank)]/[A (negative control) − A (blank)] × 100.
2.2.4. Examination of cell cycle
The cells were washed by 0.25% trypsin-digested pre-cooling
PBS 3 times after transfected for 48 h to make monoplast sus-
pension with a adjusted cell number of (1–5) × 106 cells/mL.
Pre-cooling absolute ethanol solution was added in it slowly to a
ﬁnal concentration of 75%. The sample was blended uniformly
and placed in the freezer at −20 C overnight. At the next day,
the ﬁxed sample was taken out and centrifuged at 1000 r/min for
5 min. The supernatant was discarded. Then, 3 mL pre-cooling
PBS resuspended cells was added and centrifuged at 800 rpm for
5 min. Also, the supernatant was discarded. In every tube,
200 mL RNase A (300 g/mL) resuspended cells were added
respectively and incubated for 30 min. RNA in the sample was
removed. In addition, 150 L PI dye liquor was added in every
tube and stained in dark place at 4 C for 20 min. After washed,
ﬂow cytometry (BD FACSCalibur) was used for the detection.
2.2.5. Apoptosis detected by Annexin V and PI stain
Cells were collected after trypsin digestion and centrifuged at
1000 r/min for 5 min and the supernatant was discarded. Cells
were suspended gently by PBS and counted. 1 × Annexin V
bind buffer was prepared. Then, 150 mL of the buffer was added
into every tube to suspend cells. The mixed solution of 45 mL
buffer and 5 mL Annexin V-FITC was added into every tube,
blended equally and dyed in dark place at 4 C for 20 min. After
that, 10 mL PI solution was added into every tube and mixed
evenly. After incubated in dark place at room temperature for
10–20 min, 200 mL buffer was added into every tube and ﬁnally
ﬂow cytometry was applied to test the apoptosis condition.
2.2.6. Realtime PCR
After transfection of Huh7, Trizol method was used to extract
the total RNA. Takara reverse transcription kits were used to
conduct reverse transcription in accordance with the instruction
strictly. Primer sequences used for reverse transcription and
realtime PCR were designed and compounded by Ribobio
(Guangzhou, China). SYBR realtime PCR was conducted by
ABI7500. U6 was used as a internal reference for the expression
levels of miR-520c-3p and miR-132, while GAPDH served as the
internal reference for the expression levels ofGPC3 andYAP. The
experiment results were analyzed by the 2−DDCt method.
2.2.7. Western blot
The culture medium was removed after transfection for 48 h.
The cells were washed by PBS. A total of 200 mL 1 × RIPA lysis
buffer was added into every well respectively to incubate at 4 C
for 30 min. Afterwards, a pipettor was used to buffet the cells
repeatedly and the lysis buffer was moved to the EP tube and
stored at −80 C. After testing the protein concentration by
Bradford method, equal protein was used to conduct SDS de-
natured polyacrylamide gelelectrophoresis with a constant
voltage electrophoresis of 60 V for 30 min and 120 V for 1 h.
After that, the protein was transferred nitrocellulose membrane
(Millipore) with transmembrane of 350 mA for 2 h. Five per-
centage of skim milk was enclosed to incubate speciﬁc GPC3 or
YAP primary antibodies at 4 C overnight and HRR secondary
antibody was incubated after washing. ECL developer was used.
Table 3
Apoptosis of Huh7 cells after transfected by miR-520c-3p and miR-132
(Mean ± SD, %).
Group Early Late Total
Negative control 4.06 ± 0.32 1.22 ± 0.04 5.71 ± 0.47
miR-520c-3p 9.33 ± 0.60* 6.29 ± 0.48* 17.32 ± 0.91*
miR-132 8.02 ± 0.72* 5.92 ± 0.40* 14.23 ± 2.44*
Co-transfection 13.09 ± 2.15* 12.71 ± 1.31* 25.79 ± 5.02*
Table 4
Expression of GPC3 and YAP in Huh7 cells after transfected by miR-
520c-3p and miR-132.
Group Protein expression mRNA relative expression
GPC3 YAP GPC3 YAP
Negative
control
0.93 ± 0.14 1.02 ± 0.11 0.95 ± 0.08 0.97 ± 0.08
miR-520c-
3p
0.47 ± 0.03* 0.59 ± 0.15* 0.92 ± 0.21 0.55 ± 0.14*
miR-132 0.94 ± 0.09 0.55 ± 0.04* 1.01 ± 0.16 0.23 ± 0.06*
Co-
transfection
0.42 ± 0.03* 0.24 ± 0.07* 1.14 ± 0.22 0.17 ± 0.01*
Compared with the negative control group, *P < 0.05.
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Streamed data were analyzed by FlowJo software. All data in
this study were statistically analyzed with Graphpad Prism 4.0.
Means between groups were tested by Student's t-test. Means of
three or more than three groups were analyzed by ANOVA
(P < 0.05). Differences were statistically signiﬁcant. Measure-
ment data were expressed by mean ± SD.
3. Results
3.1. The transfection effect of miR-520c-3p and miR-132
mimic
The results of realtime PCR showed that as compared to the
negative control group the level of miR-520c-3p of Huh7
transfected only by miR-520c-3p mimic or co-transfected
increased by about 150 times, while the expression level of
miR-132 of Huh7 transfected only by miR-132 mimic or co-
transfected increased by about 240 times (Table 1), which
indicated the success of mimic transfection.
3.2. Cell viabilities of hepatoma carcinoma Huh7 after
co-transfected by miR-520c-3p and miR-132
CCK8 was used to detect the cell viabilities of Huh7 after
transfected 48 h. The results showed that the cell viabilities of
Huh7 of the miR-520c-3p group and miR-132 group decreased
signiﬁcantly as compared with the control group. The cell
viability of the co-transfection group declined most distinctly
(Table 1), which proved that the over expression of miR-520c-
3p and miR-132 could inhibit the proliferation of Huh7.
3.3. Effect of the co-transfection of miR-520c-3p and
miR-132 on the cell cycle of hepatoma carcinoma Huh7
In order to conﬁrm the correlation of the cell cycle and
decrease of cell viability of Huh7 caused by miR-520c-3p and
miR-132, Ethidium bromide was used to dye the transfected
cells to analyze the cell ratios of all cell cycles. It was found thatTable 1
The expression of miR-520c-3p and miR-132 and cell viabilities of Huh7
after transfected with miR-520c-3p and miR-132.




0.98 ± 0.14 1.05 ± 0.11 98.83 ± 4.21
miR-520c-3p 145.21 ± 12.31* 0.96 ± 0.13 77.63 ± 5.10*
miR-132 1.56 ± 0.29 237.00 ± 28.10* 74.21 ± 7.92*
Co-transfection 157.23 ± 23.95* 252.88 ± 19.76* 55.34 ± 7.43*
*P < 0.05 compared with the negative control group.
Table 2
Cell cycle distribution of Huh7 after transfected with miR-520c-3p and
miR-132 (Mean ± SD, %).
Group G1 S G2
Negative control 44.07 ± 5.32 39.23 ± 5.08 15.62 ± 1.94
miR-520c-3p 58.77 ± 6.34* 30.14 ± 2.27* 10.83 ± 4.06
miR-132 61.30 ± 4.51* 28.3 ± 3.94* 13.13 ± 3.20
Co-transfection 74.32 ± 8.19* 17.23 ± 4.25* 11.42 ± 3.14
*P < 0.05 compared with the negative control group.single transfection of miR-520c-3p or miR-132 could lead to the
increase in the cell ratio during G1 phase and decreases in the
phases starting from S (P < 0.05), while the cell cycle of the co-
transfection group showed a apparent block phenomenon
(Table 2), which indicated that the co-transfection of miR-520c-
3p and miR-132 could inhibit cell cycle effectively.
3.4. Effect of the co-transfection of miR-520c-3p and
miR-132 on apoptosis of hepatoma carcinoma Huh7
In order to further explore the effect of co-transfection of
miR-520c-3p and miR-132 on apoptosis of Huh7, we applied
Annexin V and PI staining to test its apoptosis level. It was
showed in Table 3 that transfections of miR-520c-3p and miR-
132 could all cause apoptosis of hepatoma carcinoma Huh7,
and the cell proportion between early apoptosis and late
apoptosis increased obviously (P < 0.05), and the apoptosis of
the co-transfection group presented most signiﬁcant.
3.5. The expressions of GPC3 and YAP of Huh7 after
co-transfected by miR-520c-3p and miR-132
Meanwhile, western blot and realtime PCR were used
respectively to detect the protein levels of target molecule GPC3
and YAP and the level of mRNA of Huh7 after transfected by
miR-520c-3p and miR-132. As a result, we found that the pro-
tein level of GPC3 in Huh7 transfected by miR-520c-3p mimic
decreased distinctly, while its mRNA level did not changed, and
its protein level of YAP and its mRNA level all declined
signiﬁcantly. The levels of GPC3 and mRNA of the co-
transfection group remained unchanged, while its protein level
and YAP expression level reduced in the same time (Table 4).
4. Discussion
MicroRNA is a non-coding single-stranded small RNA with
a total length of 18–25 bp which regulates the expression of
target genes by inducing the degradation of target gene RNA or
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throughput sequencing technology and the analysis of the
expression proﬁle of miRNA in human tumors, the differential
expression of miRNA and its relationship with the early
diagnosis and prognosis of tumors have attached more and
more attentions. Researchers have manifested that multiple
miRNA expresses abnormally in liver cancer. They participate
in the occurrence and development of cancers by adjusting
apoptosis and cell cycle or regulating the expression of
oncogenes and tumor suppressor genes. The expression level
of miRNA can be used a mark for tumor diagnosis and
prognosis evaluation. For instance, the expressions of miR-21,
miR-122 and miRNA-101 are correlated to tumor invasion
and the increase of recurrence risks [9–11]. Moreover, miRNA in
blood or serum cannot be dissociated by RNA enzyme, which
made it more convenient to get and easier to operate. MiRNA
tested by peripheral blood is of great importance to the early
diagnosis of liver cancer. For example, miR-223, miR-122 and
miR-192 possess high accuracy in detecting early hepatocellular
carcinoma [12,13]. Results of animal experiments also prompted
that miR-26a, miR-122 and miR-124 could serve as potential
therapeutic targets to extend the survival time for mice. How-
ever, the interaction and mode of action of different miRNA in
hepatoma carcinoma cells still remain unclear. It was found in
this study the co-infection of miR-520c-3p and miR-132 on
hepatoma carcinoma Huh7 could inhibit proliferation and
stimulate apoptosis of hepatoma carcinoma cells.
miR-520c-3p is considered as a negative regulatory factor in the
growth of tumors, which presents a low expression in diffuse B cell
lymphoma, transcribes initiation factor eIF4GII by targeting
regulation and inhibits the formation of cell colonies and the growth
of tumors [14]. GPC3 is a transmembrane glycoprotein of cell
surface inducing physiological functions such as lymphocytes
homing and extracellular matrix adhesion, and its high
expression is closely related to tumorigenesis and neoplasm
metastasis [15]. There were researches conﬁrming that miR-520c-
3p could inhibit the expression of GPC3 by targeting in hepa-
toma carcinoma to inhibit the proliferation and metastasis of hep-
atoma carcinoma [7]. It was also found in this study that the cell
cycle of miR-520c-3p-over-expressed hepatoma carcinoma Huh7
was inhibited signiﬁcantly, its apoptosis ratio increased obviously,
and the protein level of its target gene GPC3 declined distinctly. At
the same time,we found that after the over expression ofmiR-520c-
3p, the expression of the core molecule YAP of the Hippo signal
pathway reduced dramatically, which indicated that the expression
of YAP was inhibited at the time the expression of GPC3 reduced.
The results were in agreement with those of the previous studies.
MiR-132 usually expresses high in nerve-related tissues
participating in the growth of axon, proliferation and differen-
tiation of synapse and angiogenesis and possessing certain
functions in immune regulation [16,17]. Studies have revealed
that miR-132 can also participate in the occurrence and devel-
opment of tumors and expresses low in tumor tissues of prostate
cancer, liver cancer and so on [18]. In prostatic cancer cells, miR-
132 can decrease the expression of pro-survival genes HB-EGF
and TALIN2 to facilitate tumor apoptosis [19]. MiR-132 can
signiﬁcantly inhibit the in vitro migration and invasion of lung
carcinoma cell through the silence of the expression of ZEB2
[20]. In hepatoma carcinoma cells, dual-luciferase report exper-
iments proved that miR-132 could combine with 30UTR of YAP
gene directly to inhibit the expression of YAP so as to inhibit the
proliferation of tumor cells [6]. We have obtained similar resultsin this study that Huh7 with over-expressed miR-132 presented
cell cycle arrest and a increase of apoptosis and the levels of
mRNA and protein of YAP reduced signiﬁcantly.
Hippo signal pathway is a cell signal pathway discovered in
fruit ﬂies. The pathway participates in the growth, differentiation
and regeneration of tissues and organs and the maintenance of
the stability of proliferation and apoptosis of body cells. Re-
searches have pointed out that the abnormal regulation of Hippo
signal pathway is closely related to the occurrence, development,
apoptosis and metastasis of tumors [21,22]. YAP is the
downstream protein playing a key role in the Hippo pathway.
The increase of its expression can lead to the increase of the
downstream transcription factor cyclin E [23], which means
that YAP can facilitate cell proliferation, inhibit cell apoptosis
and promote malignant transformation. More and more
evidences have implied that YAP, as a oncogene, presents
high expression in many human tumors such as colon cancer,
lung cancer, ovarian cancer, liver cancer, etc., and the high
expression of YAP in liver cancer is closely related to the
differentiated degree of liver cancer and high-serum AFP [24–
26]. After YAP over expresses in normal mammary epithelium,
cells can be over-productive, which facilitates the epithelial–
mesenchymal transition and inhibits cell apoptosis [27].
Disturbing the expression of YAP in tumor cells can inhibit
the growth and metastasis of tumors [28]. Hence, to explore the
intervention of the YAP expression lever to reduce tumor cells
may provide theoretical basis for treating liver cancer. The
results of this study revealed that single transfection of miR-
520c-3p and miR-132 can decrease the levels of YAP protein
and mRNA signiﬁcantly, inhibit the proliferation of hepatoma
carcinoma cells and induce apoptosis. The effect of the co-
transfection of miR-520c-3p and miR-132 was more remark-
able, which indicated the regulation effect of the target protein
GPC3 of miR-520c-3p on YAP and the silence effect of miR-
132 on YAP had a synergistic anti-tumor efﬁcacy in hepatoma
carcinoma Huh7.
In conclusion, it is found in this study that the co-transfection
of miR-520c-3p and miR-132 can inhibit the expression level of
YAP together, suppress the proliferation of hepatoma carcinoma
synergistically and promote apoptosis of hepatoma carcinoma.
The study results of this paper also suggest that the effects of
different miRNA are networked in tumor cells. Based on their
different action modes, their biological functions may overlap
with each other, which provides the theoretical basis for the
molecular intervention method for oncotherapy.
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